XAIR
Beyond Air, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.53
−1.67%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 7.7M | 7.7M | 3.7M | 1.2M | — |
| Cost of Revenue | 7.4M | 7.4M | 5.4M | 2.5M | 555.0K |
| Gross Profit | 321.0K | 252.0K | (1.7M) | (1.3M) | (555.0K) |
| Operating Expenses | |||||
| R&D Expense | 9.1M | 10.2M | 16.9M | 24.4M | 16.8M |
| SG&A Expense | 19.2M | 19.1M | 26.0M | 37.3M | 34.7M |
| General & Admin Expense | 19.2M | 19.1M | 26.0M | 37.3M | 34.7M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | (1.0K) | — |
| Total Operating Expenses | 28.4M | 29.3M | 42.9M | 61.7M | 51.5M |
| Cost and Expenses | 35.7M | 36.7M | 48.2M | 64.2M | 52.1M |
| Operating Income (EBIT) | (28.0M) | (29.0M) | (44.5M) | (63.0M) | (52.1M) |
| Non-Operating | |||||
| Interest Income | 103.0K | — | — | — | — |
| Interest Expense | 944.0K | — | 3.0M | 2.9M | 30.0K |
| Net Interest Income | (841.0K) | — | (3.0M) | (2.9M) | (30.0K) |
| Other Non-Op Income/Expense | (6.4M) | (5.3M) | (3.9M) | (1.3M) | (7.3M) |
| Non-Operating Income (excl Interest) | 5.2M | 5.3M | 923.0K | (1.6M) | 7.3M |
| EBT (Pre-Tax Income) | (34.4M) | (34.3M) | (48.5M) | (64.3M) | (59.4M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (33.5M) | (33.2M) | (46.6M) | (60.2M) | (55.8M) |
| Earnings from Cont. Ops | (34.4M) | (34.3M) | (48.5M) | (64.3M) | (59.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (33.5M) | (33.2M) | (46.6M) | (60.2M) | (55.8M) |
| Per Share | |||||
| Basic EPS | ($53.60) | ($4.01) | ($275.40) | ($726.60) | ($744.80) |
| Diluted EPS | ($53.60) | ($4.01) | ($275.40) | ($726.60) | ($744.80) |
| Revenue Per Share | $10.66 | $0.93 | $21.89 | $13.98 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 721328 | 8.3M | 169266 | 82900 | 74934 |
| Diluted Shares Outstanding | 721328 | 8.3M | 169266 | 82900 | 74934 |
| Profitability Metrics | |||||
| EBITDA | (31.1M) | (31.2M) | (41.9M) | (59.0M) | (58.2M) |
| D&A | 2.2M | 3.1M | 3.6M | 2.4M | 1.2M |
| EBIT | (33.3M) | (34.3M) | (45.5M) | (61.4M) | (59.4M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026